Literature DB >> 1797589

Initial characterization of the four promoters of the human insulin-like growth factor II gene.

M A van Dijk1, F M van Schaik, H J Bootsma, P Holthuizen, J S Sussenbach.   

Abstract

The human insulin-like growth factor II (IGF-II) gene contains four promoters (P1-P4), which are expressed in a tissue-specific and development-dependent way. Analysis of IGF-II mRNAs in different tissues has revealed that promoters P3 and P4 are expressed in all fetal and in nonhepatic adult tissues. In adult liver, however, the promoters P2, P3 and P4 are completely shut off and another promoter, P1, is activated. To obtain more insight in the mechanisms involved in the regulation of IGF-II gene expression we have performed an initial characterization of the IGF-II promoters employing transient expression of IGF-II promoter constructs in Hep3B and HeLa cells. These studies have revealed that promoters P1, P3 and P4 are active in both cell lines tested, while no activity of promoter P2 could be detected. Employing gel retardation and DNaseI footprint analysis we have identified in the three IGF-II promoters a number of elements which are bound by nuclear proteins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1797589     DOI: 10.1016/0303-7207(91)90207-9

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  25 in total

1.  Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma.

Authors:  J Anderson; A Gordon; A McManus; J Shipley; K Pritchard-Jones
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

Review 2.  The insulin-like growth factor family of ligands, receptors, and binding proteins.

Authors:  R F Krywicki; D Yee
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

3.  Identification of a key regulatory element for the basal activity of the human insulin-like growth factor II gene promoter P3.

Authors:  L E Rietveld; P E Holthuizen; J S Sussenbach
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

Review 4.  Transcriptional regulation and biological significance of the insulin like growth factor II gene.

Authors:  W Engström; A Shokrai; K Otte; M Granérus; A Gessbo; P Bierke; A Madej; M Sjölund; A Ward
Journal:  Cell Prolif       Date:  1998 Oct-Dec       Impact factor: 6.831

5.  Differential regulation of IGF-I and IGF-II gene expression in skeletal muscle cells.

Authors:  Shuang Jiao; Hongxia Ren; Yun Li; Jianfeng Zhou; Cunming Duan; Ling Lu
Journal:  Mol Cell Biochem       Date:  2012-10-10       Impact factor: 3.396

6.  Insulin-like growth factor II is involved in the proliferation control of medulloblastoma and its cerebellar precursor cells.

Authors:  Wolfgang Hartmann; Arend Koch; Hendrik Brune; Anke Waha; Ulrich Schüller; Indra Dani; Dorota Denkhaus; Wilhelma Langmann; Udo Bode; Otmar D Wiestler; Karl Schilling; Torsten Pietsch
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

7.  Six mRNAs with different 5' ends are encoded by a single gamma-glutamyltransferase gene in mouse.

Authors:  S Rajagopalan; D F Wan; G M Habib; A R Sepulveda; M R McLeod; R M Lebovitz; M W Lieberman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

8.  Dual role for transcription factor AP-2 in the regulation of the major fetal promoter P3 of the gene for human insulin-like growth factor II.

Authors:  L E Rietveld; A M Koonen-Reemst; J S Sussenbach; P E Holthuizen
Journal:  Biochem J       Date:  1999-03-15       Impact factor: 3.857

9.  Transactivation of mouse insulin-like growth factor II (IGF-II) gene promoters by the AP-1 complex.

Authors:  A Caricasole; A Ward
Journal:  Nucleic Acids Res       Date:  1993-04-25       Impact factor: 16.971

10.  Site-specific cleavage of IGF-II mRNAs requires sequence elements from two distinct regions of the IGF-II gene.

Authors:  D Meinsma; W Scheper; P E Holthuizen; J L Van den Brande; J S Sussenbach
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.